All PlansPrior AuthMedium impact
Newsletter Vol. 11, No. 51
New Jersey Medicaid·NJ · Infectious Disease, Endocrinology, Internal Medicine·Provider Notice
We identified it
Jun 20, 2026
Summary
New prior drug utilization review (PDUR) standards have been established for Somatropin when used to treat HIV-associated wasting syndrome. This likely introduces new prior authorization requirements or coverage criteria that must be met before prescribing this growth hormone therapy.
Action Required
Immediately: Review the full Newsletter Vol. 11, No. 51 document at the provided URL to understand specific PDUR requirements for Somatropin in HIV-associated wasting cases. Update prior authorization workflows and inform providers who treat HIV patients about new coverage standards. Ensure documentation requirements are met before prescribing.